targeted therapy

2019 ASCO ® Annual Meeting; #ASCO19
May 15, 2019 · Greg Guthrie, ASCO staff
Read research highlights that will be presented at the 2019 ASCO Annual Meeting, covering low-fat diets and risk of breast cancer death, chemotherapy for older adults with esophageal cancer, targeted therapy for those at risk for multiple myeloma, the rate of genetic changes in childhood cancers, and a new targeted therapy for childhood central nervous system tumors. Read More >>
Genitourinary Cancers Symposium
February 11, 2019 · Greg Guthrie, ASCO Staff
The 2019 Genitourinary Cancers Symposium will feature new research on treatments for prostate cancer and kidney cancer. Read More >>
ASCO ® American Society of Clinical Oncology; Clinical Cancer Advances 2019: ASCO's Annual Report on Progress Against Cancer
January 31, 2019 · Greg Guthrie, ASCO Staff
In 2019, ASCO recognizes the progress in treating rare cancers as the Advance of the Year. Impressive progress has been made in bringing new treatment advances to cancers that are rare and difficult to treat. This year’s Clinical Cancer Advances report describes emerging treatments for thyroid cancer, uterine cancer, desmoid tumor, neuroendocrine tumor, and tenosynovial giant cell tumor. Read More >>
Nora Lynn Henry, MD
January 29, 2019 · Greg Guthrie, ASCO staff
In this podcast, Lineagotica Associate Editor Dr. Lynn Henry describes a clinical trial that studied a new approach to treating HER2-positive breast cancer. Read More >>
January 8, 2019 · Greg Guthrie, ASCO staff
In this podcast, Dr. Brian Rini and Dr. Jorge Garcia discuss the latest research in genitourinary cancers presented at the 2018 ESMO Congress. Read More >>

Pages